A new study suggests that ketamine significantly improves depression and anhedonia symptoms by altering brain connectivity in the anterior cingulate cortex, specifically influencing different subregions linked to mood regulation and reward processing. The findings have been published in Translational Psychiatry.
A study published in Nature Medicine shows MDMA-assisted therapy significantly reduces symptoms in individuals with severe PTSD, offering promising results for those unresponsive to traditional treatments, and is well-tolerated with few side effects.
A new study provides evidence that the lingering effects of hallucinogenic drugs, known as Hallucinogen Persisting Perception Disorder (HPPD), are more common among users than previously understood.
Stanford researchers found that a combination of magnesium and ibogaine significantly reduced symptoms of PTSD, depression, and anxiety in veterans with traumatic brain injuries. The treatment also improved cognitive functions.
A study analyzed Reddit posts to investigate how psilocybin affects self-perception and recognition in mirror gazing, finding it tends to enhances positive self-perception without impairing self-recognition.
Recent psychedelic research shows promising results for mental illnesses and eating disorders, with surveys and reports indicating psilocybin-assisted therapy's potential. However, challenges in research methodology, patient safety concerns, and the need for cautious optimism highlight the gap between scientific evidence...
Socially anxious individuals drink more in the presence of strangers, a study using smartphone surveys and alcohol sensors reveals. Familiarity in social settings inversely affects their alcohol consumption.
A study in Brazil examines the spiritual well-being of psychedelic users and non-users, revealing distinct experiences and emphasizing the need for inclusive spirituality assessment tools.
Doxycycline, an antibiotic, shows promise in reducing addictive effects of drugs like morphine and cocaine, offering new treatment avenues for substance use disorders. These findings, though preliminary and based on male mice, suggest potential for more effective interventions against addiction.
Psilocybin-assisted group therapy might help reduce depression in cancer patients. This innovative approach, blending psychedelic effects with psychological support, has demonstrated promising results in improving mental health and quality of life for these patients.
Despite high hopes, a recent study reveals that a 300mg dose of cannabidiol fails to alleviate cognitive anxiety symptoms, challenging its perceived anxiolytic benefits and prompting a reevaluation of its therapeutic potential. The study was published in Psychopharmacology.
A new study shows how depression alters brain connectivity, particularly in the habenula, and how ketamine treatment reverses these changes. This research enhances understanding of depression and ketamine's rapid antidepressant effects.
New research published in Scientific Reports provides insights into the long-term negative psychological effects of psychedelic drugs. The study helps to identify potential risk factors for persistent anxiety, panic, and other psychological issues following the use of substances such as...
Researchers have discovered significant differences in white matter between regular cannabis users and non-users, indicating potential impacts on brain function. The findings highlight the need for further investigation into cannabis's effects on neurodevelopment.
Scientists at Enveric Biosciences have created novel psilocybin derivatives, potentially offering therapeutic mental health benefits with reduced psychedelic effects. This research paves the way for new treatments for depression and anxiety.